Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 23 (RN7SKP23) is a human pseudogene; pseudogenes are non-functional DNA sequences similar to known genes, originally formed through gene duplication or retrotransposition. Unlike its functional paralog RN7SK, which encodes a long noncoding RNA involved in the regulation of RNA polymerase II transcription elongation and macrophage polarization[1][3], RN7SKP23 does not perform known biological functions and is not linked to disease or therapeutics[2]. RN7SKP23 should not be considered a therapeutic target. The functional molecule is RN7SK (RNA component of 7SK nuclear ribonucleoprotein), which plays roles in transcriptional regulation and immune cell polarization, but RN7SKP23 is simply a genomic copy and not expressed as a functional RNA or protein[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 23 (RN7SKP23).